Sysmex (OTCMKTS:SSMXY) Sees Strong Trading Volume – Still a Buy?

Sysmex Corporation ADR (OTCMKTS:SSMXY) shares saw an uptick in trading volume on Monday. Approximately 229,861 shares were traded during trading, an increase of 27% from the previous session’s volume of 180,761 shares. The stock last traded at $12.03 and had previously closed at $12.13.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Sysmex from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 18th. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold”.

Sysmex Trading Down 2.4%

The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.53 and a current ratio of 3.40. The company’s 50 day simple moving average is $11.41 and its two-hundred day simple moving average is $9.75. The stock has a market cap of $7.45 billion, a price-to-earnings ratio of 28.19 and a beta of 1.09.

Sysmex (OTCMKTS:SSMXY) last issued its quarterly earnings results on Friday, August 7th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.02. The company had revenue of $825.85 million for the quarter, compared to the consensus estimate of $741.67 million. Sysmex had a return on equity of 8.01% and a net margin of 7.62%.Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. Research analysts expect that Sysmex Corporation ADR will post 0.42 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic instruments, reagents and related information systems. Its products are primarily used in clinical laboratories, hospitals and other healthcare settings to support the analysis of blood, urine and other biological samples.

The company is best known for its hematology testing systems, including automated analyzers used to assess blood cell counts and related parameters. Its portfolio also includes products for hemostasis and coagulation testing, urinalysis, clinical chemistry, immunochemistry and flow cytometry, as well as laboratory information systems, maintenance and other support services.

Sysmex was established in 1968 and is headquartered in Kobe, Japan.